Eko-Oze Past Earnings Performance

Past criteria checks 0/6

Eko-Oze's earnings have been declining at an average annual rate of -80.5%, while the Healthcare industry saw earnings growing at 4% annually. Revenues have been declining at an average rate of 13.2% per year.

Key information

-80.5%

Earnings growth rate

-40.5%

EPS growth rate

Healthcare Industry Growth13.7%
Revenue growth rate-13.2%
Return on equity-412.4%
Net Margin-54,402.9%
Next Earnings Update14 Nov 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Eko-Oze makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

WSE:EKE Revenue, expenses and earnings (PLN Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 230-1000
30 Jun 230-900
31 Mar 230-900
31 Dec 220-1000
30 Sep 220000
30 Jun 220000
31 Mar 220000
31 Dec 210000
30 Sep 210000
30 Jun 210000
31 Mar 210000
31 Dec 200000
30 Sep 200000
30 Jun 200000
31 Mar 200000
31 Dec 190000
30 Sep 190000
30 Jun 190000
31 Mar 190000
31 Dec 180000
30 Sep 180-100
30 Jun 180-100
31 Mar 180-100
31 Dec 170-100
30 Sep 170000
30 Jun 170000
31 Mar 170000
31 Dec 161000
30 Sep 161010
30 Jun 162010
31 Mar 162020
31 Dec 152020
30 Sep 152020
30 Jun 152010
31 Mar 151010
31 Dec 141000
30 Sep 140000
30 Jun 140-110
31 Mar 140-110
31 Dec 130-110
30 Sep 131-110

Quality Earnings: EKE is currently unprofitable.

Growing Profit Margin: EKE is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: EKE is unprofitable, and losses have increased over the past 5 years at a rate of 80.5% per year.

Accelerating Growth: Unable to compare EKE's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: EKE is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (11.6%).


Return on Equity

High ROE: EKE has a negative Return on Equity (-412.37%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies